B.D. Bax
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Toxicology top 1%
Papers in ⓘ
- Toxicology 11
- Bioactive Compounds and Antitumor Agents 11
-
- Calcium signaling and nucleotide metabolism 5
- Co-authors
- Jörg Müssig (1 shared paper)Peter F. Lindley (6 shared papers)Tom L. Blundell (6 shared papers)C. Slingsby (7 shared papers)Pan F. Chan (7 shared papers)H.P.C. Driessen (7 shared papers)V. Nalini (3 shared papers)G.L. Card (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Molecular Biology (5 papers)Nucleic Acids Research (4 papers)Structure (4 papers)Biochemical Journal (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
B.D. Bax
70 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 149
- Molecular Medicine 290
- Toxicology 170
- Molecular Biology 2.4k
- Polymers and Plastics 421
- Biomaterials 383
Countries citing papers authored by B.D. Bax
This map shows the geographic impact of B.D. Bax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.D. Bax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.D. Bax more than expected).
Fields of papers citing papers by B.D. Bax
This network shows the impact of papers produced by B.D. Bax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.D. Bax. The network helps show where B.D. Bax may publish in the future.
Co-authors
The 25 scholars most cited alongside B.D. Bax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 491 | |
| 2 | 1994 | 295 | |
| 3 | 1996 | 290 | |
| 4 | 2010 | 242 | |
| 5 | 1990 | 219 | |
| 6 | 2001 | 172 | |
| 7 | 2018 | 146 | |
| 8 | 2015 | 122 | |
| 9 | 2019 | 122 | |
| 10 | 1992 | 112 | |
| 11 | 1998 | 101 | |
| 12 | 2015 | 90 | |
| 13 | 1995 | 89 | |
| 14 | 2019 | 83 | |
| 15 | 2001 | 80 | |
| 16 | 1991 | 80 | |
| 17 | 2017 | 64 | |
| 18 | 2014 | 58 | |
| 19 | 2010 | 57 | |
| 20 | 2014 | 56 |
About B.D. Bax
B.D. Bax is a scholar working on Toxicology, Physiology, Molecular Medicine, Molecular Biology and Cell Biology, having authored 70 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (17 papers), Bioactive Compounds and Antitumor Agents (11 papers), Enzyme Structure and Function (10 papers), Connexins and lens biology (8 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Calcium signaling and nucleotide metabolism (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Molecular Medicine (290 citations), Toxicology (170 citations), Molecular Biology (2.4k citations), Polymers and Plastics (421 citations) and Biomaterials (383 citations). B.D. Bax has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Jörg Müssig, Peter F. Lindley, Tom L. Blundell, C. Slingsby, Pan F. Chan, H.P.C. Driessen, V. Nalini, G.L. Card, I. Zaitseva and A. Ralph. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Molecular Biology, Nucleic Acids Research, Structure and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.